The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Keral 50 mg/2ml solution for injection/infusion



Menarini International Operations Luxembourg S.A.PA0865/002/003

Main Information

Trade NameKeral 50 mg/2ml solution for injection/infusion
Active SubstancesDexketoprofen trometamol
Dosage FormSolution for injection/infusion
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberPA0865/002/003

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE17 dexketoprofen

Status

License statusAuthorised
Licence Issued19/03/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back